<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This pictorial essay illustrates the usefulness of diffusion-weighted imaging (DWI) on various <z:hpo ids='HP_0002633'>vasculitis</z:hpo> or vasculopathies, including <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease, Churg-Strauss disease, primary angitis of the central <z:mp ids='MP_0008912'>nervous</z:mp> system (PACNS), giant cell <z:hpo ids='HP_0012089'>arteritis</z:hpo>, infectious <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle cell disease</z:e>, drug-induced vasculopathy and hypertensive vasculopathy </plain></SENT>
<SENT sid="1" pm="."><plain>DWI proves to detect small and active ischemic changes not visible on conventional MRI, and it clearly discriminates cytotoxic from vasogenic <z:hpo ids='HP_0000969'>edema</z:hpo> in patients with <z:hpo ids='HP_0005318'>cerebral vasculitis</z:hpo> or vasculopathy </plain></SENT>
<SENT sid="2" pm="."><plain>DWI seems useful in assessing the treatment and patient outcome </plain></SENT>
</text></document>